Technical Advisory Group meeting, WHO/WPRO

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

Diseases without borders What must the Global Development Community Do? World Bank Seminar Series Tawhid Nawaz, Operations Advisor Human Development Network.
GIM meeting Feb |1 | Global Action Plan for Prevention and Control of Pneumonia (GAPP) and progress S. Qazi and T Cherian On behalf of the GAPP.
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
Global Measles and Rubella Strategic Plan
Dr. E. Anne Peterson, MD, MPH Assistant Administrator, Bureau for Global Health, USAID Sustainable Investment and Donor Coordination Stop TB Partners Forum.
Overview of the Global Fund: Guiding Principles Grant Cycle / Processes & Role of Public Private Partnerships Johannesburg, South Africa Tatjana Peterson,
The U.S. President’s Emergency Plan for AIDS Relief The Evolving HIV Prevention Strategy for IDUs in PEPFAR Amb. Eric Goosby US Global AIDS Coordinator.
Ram Deo Chaudhary Programme Manager, BNMT. Outlines VMGO of BNMT Guiding principles of partnership Historical background Current efforts Strengths Area.
REPORT HIGHLIGHTS “Children should be the first to benefit from our successes in defeating HIV, and the last to suffer from our failures.” Anthony Lake,
End TB strategy target setting
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Almost 14 years ago all countries endorsed a set of 8 Millennium Development Goals (or MDGs). 3 of those 8 Goals focus on health – that being child mortality,
Global Plan to Stop TB Stop TB Partnership
China TB Control Progress Report The ninth Technical Advisory Group and National TB Programme Managers meeting for TB control in the Western Pacific Region.
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
Global Health Program Guiding Principles April 2002.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Departmental Perspectives on Viral Hepatitis
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
PUTTING AN END TO TB WHERE ARE THE OPPORTUNITIES AND WHAT ARE THE CHALLENGES? STRATEGY MEETING ON RESOURCE MOBILIZATION FOR THE GLOBAL FUND TO FIGHT AIDS,
“A VISION OF HOPE” EXPERIENCE OF SENEGAL IN THE FIGHT AGAINST AIDS AND REDUCING WOMEN’S VULNERABILITY Dr Khoudia Sow, CRCF, UMI 233 Dakar Sénégal.
THE FIGHT TO STOP TB WHAT ARE WE FIGHTING? TUBERCULOSIS: THE WORLD’S NO. 1 KILLER AMONG CURABLE, INFECTIOUS DISEASES But there is hope PEOPLE WHO HAVE.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
COUNTRY ACTION: SUSTAINABLE INVESTMENT STOP TB PARTNERSHIP FORUM STOP TB PARTNERSHIP FORUM 24TH-26TH MARCH TH-26TH MARCH 2004 BY BY MRS NENADI USMAN.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
TB Research Challenge in Indonesia
The Global Fund- structure, function and evolution February 18, 2008.
WHO Expert Working Group on R&D Financing Stop TB New Tools Working Groups Marcos Espinal Executive Secretary.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Session 11: MDR & XDR-TB: How Can Business Help Stem the Tide?
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
End TB Strategy HCW with cough since January. Seen at government clinic thrice with no sputum/CXR. Diagnosed TB in May only.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
INAT and Research Christian Lienhardt Stop TB Partnership Geneva First Meeting of the Core Group of the Subgroup on Introducing New Tools and Approaches.
1 [INSERT SPEAKER NAME DATE & LOCATION HERE] Ethics of Tuberculosis Prevention, Care and Control MODULE 2: BACKGROUND ON TUBERCULOSIS Insert country/ministry.
Proposed Post-2015 Global Tuberculosis Strategy and Targets Dr Mario Raviglione Director, Global TB Programme World Health Organization, Geneva, Switzerland.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Mario C. Raviglione, M.D. Director, Stop TB Department WHO, Geneva, Switzerland TB prevention, care and control, : Framing global and WHO strategic.
Philippe Duneton11 February 2009 Deputy Executive Secretary 5th Consultative Stakeholder Meeting UN Prequalification of Diagnostics, Medicines & Vaccines.
Moving ahead with the Stop TB Strategy: where are we today? Dr Mario Raviglione Director, WHO Stop TB Department Joint Meeting of Core Teams and High Burden.
Meeting of the Working Group on TB Drug Development Why you need to be engaged? Marcos Espinal Executive Secretary Stop TB Partnership 29 October 2004.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
Policies and strategies to expand ECCE: what makes a difference in countries Input from UNGEI technical meeting.
The Bank’s Regional HIV/AIDS Strategies An Overview.
Tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
World Health Organization
Outline The Global Fund Strategy emphasizes the Key Populations
financial requirements
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Country Progress Report Cambodia
La tubercolosi nel terzo millennio
8-9 August 2009, Bali, Indonesia
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Sunday, 22 July, 07:30-20:00 Room Elicium 1, RAI Amsterdam
Committee Task Statement (1)
ДЭМБ, Сүрьеэтэй тэмцэх стратеги он: Бүсийн хэтийн төлөвлөгөө
Convegno, Stop TB Italia – Milano,
Knowledge gaps in formulating TB Control Policies for Prisons
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
5th DEWG meeting Conclusions
Millennium Development Goals (MDGs)
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
Presentation transcript:

Technical Advisory Group meeting, WHO/WPRO The End TB Strategy Role of WHO in supporting implementation of the new global strategy Philippe Glaziou, on behalf of Mario RAVIGLIONE, Director Technical Advisory Group meeting, WHO/WPRO Manila 9-12 December 2014

Global Burden of TB in 2013 1.5 million 9 million 480,000 Estimated number of cases Estimated number of deaths 1.5 million 80,000 in children 510,000 in women 9 million 126 per 100,000 550,000 in children 3.3 m in women 480,000 All forms of TB Multidrug-resistant TB HIV-associated TB 1.1 million (13%) 360,000 210,000

TB cases and deaths, 1990–2013 9 million incident cases in 2013 5.7 million reported to WHO 1.5 million deaths in 2013 All cases HIV-negative HIV-positive cases 1.1m HIV-positive

480,000 MDR-TB, 9% with XDR Highest % in the former USSR countries India, China, Russia, Pakistan and Ukraine have 60% of all MDR-TB cases

Accelerated MDR detection, but widening treatment gap 136,000 detected (2013) Accelerated MDR detection, but widening treatment gap 97,000 treated (2013)

48% MDR treatment success globally

MDR-TB: Five priority actions

78% of TB/HIV cases in Africa Response to TB/HIV means cutting transmission and mortality 78% of TB/HIV cases in Africa Other co-morbidities emerging in other regions

48% global HIV testing coverage, 76% in Africa

Intensifying research The needs are clear: Understand pathogenesis & immunity PoC diagnostic tests Short regimens incl. for LTBI Post-exposure vaccine Epidemiological, health system, implementation research

Funding gap US$ 8 billion per year required for the response US$ 2 billion gap US$ 2 billion required for R&D Cost per case US$ 100-500 Cost per MDR case US$ 9,000-49,000

Global progress on impact - 2014 TARGETS ON TRACK Reduction in TB mortality rate of 45% since 1990 37 million lives saved since 2000 86% cure rate and 61 million patients cured, 1995-2013 BUT…. incidence falling too slowly at 1.5%/year

Challenges: 5 priorities for action 5 PRIORITIES TO ELIMINATE TB Reaching the “missed” cases (3 million not in the system) Address MDR-TB as crisis Accelerate response to TB/HIV Increase financing to close resource gaps Intensify research and ensure rapid uptake of innovations

67th World Health Assembly, Geneva, May 2014

Global projections to 2035

The End TB Strategy: Vision, goal, targets Vision: A world free of TB Zero TB deaths, Zero TB disease, and Zero TB suffering Goal: End the Global TB epidemic (<10 cases per 100,000) Target 1 95% reduction in deaths due to TB (compared with 2015) Target 2 90% reduction in TB incidence rate (compared with 2015) Target 3 No affected families face catastrophic costs due to TB

3 pillars and 4 Principles Bold policies and supportive systems Integrated, patient-centered TB care and prevention Intensified research and innovation Government stewardship and accountability, with monitoring and evaluation Building a strong coalition with civil society and communities Protecting and promoting human rights, ethics and equity Adaptation of the strategy and targets at country level, with global collaboration

The End TB Strategy components 1. INTEGRATED, PATIENT-CENTRED CARE AND PREVENTION Early diagnosis, universal DST, screening of contacts and high-risk groups Treatment of all, including DR-TB, patient support Collaborative TB/HIV activities, management of co-morbidities Preventive treatment of persons at high risk, vaccination against tuberculosis 2. BOLD POLICIES AND SUPPORTIVE SYSTEMS Political commitment, adequate resources for tuberculosis care and prevention Engagement of communities, civil society, and public and private care providers Universal health coverage policy, regulatory frameworks for notification, vital registration, rational use of medicines, infection control Social protection, poverty alleviation and actions on other determinants of TB 3. INTENSIFIED RESEARCH AND INNOVATION Discovery, development, rapid uptake of new tools Research to optimize implementation, impact - promote innovations

“Global Consultation Towards Elimination of Tuberculosis in Countries with Low Incidence of Disease” Rome, 4-5 July 2014 Countries with < 10/100,000 TB cases/year, notified all forms cases & > 300k population Other countries progressing rapidly or with potential to consider elimination in the future

Targets for low-incidence countries <100 cases per million Current TB burden-2012 in low-incidence countries   <10 cases per million Pre-elimination: 2035 in low-incidence countries   <1 case per million Elimination: 2050  

Way forward: What will WHO do globally? Norms, strategies and policies Global M&E for impact and progress Adaptation towards elimination in low-incidence countries Support ROs' efforts in adopting & adapting Guidance on adoption and adaptation of the new strategy Access to innovations Focus on the most vulnerable populations Multi-sectoral partnerships for social protection Promotion of research and innovation Advocacy and promotion of the new strategy Investment plan with partners for resource mobilization Investment plan

What will WHO do in countries? Technical assistance to adapt, plan, and implement the new strategy with focus on: Vulnerable communities Missed cases, TB/HIV and MDR-TB Monitoring & evaluation Research, application of innovations Social development Support in resource mobilization Partnership with GF on TA for epidemiological assessment, programme reviews, NSP, and concept note development Partnership with UNITAID to strengthen diagnostic capacity and access to new/essential commodities Close collaboration with other international donors

Conclusions Global achievements also depend on success in the regions, especially WPR, with nearly 20% of the global burden Reaching the 2025 and 2035 targets in WPR requires… In middle- and high-incidence countries: full adoption, financing and implementation of the new End TB Strategy; In low-incidence countries, TB Elimination Action Framework, intensified support to higher-incidence countries WHO’s Global TB Programme committed to support all efforts by countries in WPR and by WHO/WPRO to make TB elimination a reality